Why Are Some Black Americans With Bipolar Disorder Going Undiagnosed?

Why Are Some Black Americans With Bipolar Disorder Going Undiagnosed?

Illustrated graphic asking "Why are some Black Americans With Bipolar Disorder Going Undiagnosed?" With these answers: Socioeconomic factors that ultimately limit access to diagnosis and proper care, Cultural barriers between doctors and patients, Misunderstanding and stigma about mental illness

Monday, July 25, 2022 - 1:00pm

CAMPAIGN: Alkermes: Diversity, Inclusion & Belonging

CONTENT: Multimedia with summary

Although Black Americans have the same rate of bipolar disorder as other racial and ethnic groups, they are less likely to receive a diagnosis due to lack of access and cultural stigma. Check out the facts and consider sharing this resource with a friend: https://mhanational.org/bipolar-disorder-and-black-americans?sf167604932=1

About Alkermes

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.